MapReduce can be used for genomic sequencing analysis, helping to identify mutations and genetic markers associated with cancer. It can also assist in clinical trials by aggregating and analyzing patient data to determine the efficacy of treatments. Additionally, MapReduce can be used to mine electronic health records (EHRs) for patterns and trends that could indicate cancer risk factors.
